Navigation Links
Insmed Provides Update on Supply of IPLEX(TM)
Date:7/27/2009

RICHMOND, Va., July 27 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today announced that, effective immediately, the Company will cease the supply of IPLEX((TM)) to any new patients. In addition, the Company will not initiate further clinical trials with IPLEX((TM)) at this time. The Company has determined that its limited inventory on hand must be conserved for the treatment of existing patients.

Following the previously announced sale of Insmed's Boulder, Colorado manufacturing facility to Merck & Co., Inc. in March 2009, Insmed no longer has the capability to manufacture IPLEX((TM)), an extremely complicated drug to produce. Moreover, any agreement with a third party to undertake the manufacture of IPLEX((TM)), if it was economically feasible and could be arranged, would not result in production of additional quantities of IPLEX(TM) for at least 12 to 18 months.

There are approximately 70 patients who currently receive IPLEX(TM), 12 in the U.S. and the remainder around the rest of the world. Most of the patients receive IPLEX(TM) pursuant to a court-ordered Extended Access Program (EAP) for Amyotrophic Lateral Sclerosis (ALS) in Italy. The 12 U.S. patients are being treated for ALS under single patient Investigational New Drug applications approved by the U.S. Food and Drug Administration. The Company believes that it has sufficient IPLEX(TM) inventory to supply these patients for no more than 24 months.

The Company intends to analyze the on-going data collected for various indications, including myotonic muscular dystrophy and ALS, and assess the overall IPLEX(TM) development program, including possible IPLEX(TM) manufacturing options with third parties and possible future clinical trials. Initiation of the Phase II clinical trial fo
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
2. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
3. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
4. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
5. Insmed to Present at Upcoming Healthcare Conferences
6. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
7. President Obamas Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model
8. Study provides documentation that tumor stem-like cells exist in benign tumors
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. International Isotopes Inc. Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction Process Plant
11. Leading Los Angeles Clinic (laserandveinclinic.com) Provides Top Notch Aesthetic Laser Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... A young couple from a small ... in the media today about parents accidentally leaving children ... of minutes in a hot car. July 31 is ... Emergency Medical Services at NHTSA. , Shaun and Kimberly ... that it’s all too easy to get distracted, the ...
(Date:7/28/2014)... Mediaplanet announced distribution of ... 12th, a campaign that aims to raise awareness about ... industry leader TEALUX , a premium loose leaf ... campaign provides readers with educational insight about the accessibility ... the industry forward and make conscious organic choices an ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The website, ... for the healthcare industry, went live in January 2014. ... the basic standards of excellence that comprise the web’s ... excellence in Healthcare. , “What pleases me the most ... content and usability categories,” said Joshua Snow, web manager, ...
(Date:7/28/2014)... According to a new market research ... IV-IV, sapphire), Deposition Technology (CVD, MBE, HVPE, ... and Geography-2013-2020", published by MarketsandMarkets, the market is ... from 2014 to 2020 and reach $104.55 billion ... and 88 figures spread through 342 pages and ...
(Date:7/28/2014)... Lake City, Utah (PRWEB) July 28, 2014 Irresistible ... gift delivered by Spoonful of Comfort. The online gifting company specializes ... they are practical. , The New Baby package starts with home-from-the-hospital ... jar of soup , 6 rolls , ... smiles , The soup is ready to heat and ...
Breaking Medicine News(10 mins):Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Abington Health Website Named Best in Class 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... concerns about erosion of RN and patient care ... today criticized the action by the Service Employees ... affiliate, United Healthcare Workers-West.In a statement today, Rose ... registered nurses in most of the hospitals where ...
... called astrocytes help to cause the urge to sleep that ... funded by the National Institutes of Health. The cells ... are inhibited by caffeine. , "Millions of Americans suffer from ... from pilots to combat soldiers have jobs where sleepiness ...
... Wednesday,s winter storm has impacted the blood ... blood drives were cancelled or postponed on Wednesday ... appointments, resulting in a 32.5% reduction of Penn-Jersey ... 6 blood drives that were scheduled to collect ...
... help spread awareness of Foundation,s mission and servicesSHORT HILLS, ... Foundation, the national, non-profit organization dedicated to finding cures ... lives of people living with paralysis, announced today that ... show "Brothers and Sisters," has been named a celebrity ...
... over 20 now have the condition, while 30% are pre-diabetic, ... most recent analysis of data on diabetes in the United ... and older have the condition, 40 percent of whom have ... patients than noted in a previous study, although the percentage ...
... Washington, D.C. A three-year award from the ... of Population Affairs to Georgetown University,s Institute for ... in California and Massachusetts to offer the Standard ... planning method developed by Institute researchers. , In ...
Cached Medicine News:Health News:CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards 2Health News:Support cells, not neurons, lull the brain to sleep 2Health News:Support cells, not neurons, lull the brain to sleep 3Health News:Blood Donors Needed in Wake of Winter Storm 2Health News:Dave Annable Named Christopher & Dana Reeve Foundation Ambassador 2Health News:Diabetes Keeps Rising Among U.S. Adults 2Health News:Diabetes Keeps Rising Among U.S. Adults 3Health News:Bringing easy-to-use, effective natural family planning to American women 2
(Date:7/28/2014)... 2014  Array BioPharma Inc. (Nasdaq:   ARRY) ... quarter and full year of fiscal 2014 ... those results on Tuesday, August 12, 2014.  ... Michael Carruthers , Chief Financial Officer will ... 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass Code: ...
(Date:7/28/2014)...  Houston dentist , Dr. Behzad ... with Invisalign. With access to this increasingly popular ... straightened without feeling self-conscious in the process. Invisalign ... types of braces, but patients who choose Invisalign ... better support for their oral health and comfort ...
(Date:7/28/2014)... , 28 luglio 2014 ResMed (NYSE: ... prodotti per la cura dei disturbi respiratori del sonno ... avuto un,ingiunzione permanente in Germania contro il produttore Taiwanese ... la vendita di apparecchiature da indossare in testa, che ... le maschere 220. La sentenza della Corte Regionale Distrettuale ...
Breaking Medicine Technology:Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: